These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15724597)

  • 1. [Blood transfusion and blood-derived products: indications, complications. Haemovigilance].
    Courbil R; Quaranta JF
    Rev Prat; 2004 Dec; 54(19):2177-86. PubMed ID: 15724597
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical problems in the use of blood and blood substitutes.
    Eichner ER
    Surg Annu; 1982; 14():85-99. PubMed ID: 7179062
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood transfusion: old blood, new blood or no blood.
    Duggan JM
    Intern Med J; 2011 Apr; 41(4):358-9. PubMed ID: 21507166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and utility of blood substitutes.
    Winslow RM
    Dev Biol (Basel); 2000; 102():167-82. PubMed ID: 10794104
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion of blood and blood substitutes: indications, contraindications and risks.
    Rudowski W
    Acta Med Pol; 1981; 22(2):161-80. PubMed ID: 7315512
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemoglobin-based blood substitutes and risk of myocardial infarction and death.
    Sauaia A; Moore EE; Banerjee A
    JAMA; 2008 Sep; 300(11):1297; author reply 1298-9. PubMed ID: 18799440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Posttransfusion reactions to the use of blood substitutes].
    Shabalin VN; Litmanovich KIu; Sabel'nikov VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):39-45. PubMed ID: 6185943
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemoglobin-based blood substitutes and risk of myocardial infarction and death.
    Sarani B; Gracias V
    JAMA; 2008 Sep; 300(11):1297-8; author reply 1298-9. PubMed ID: 18799439
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rational hemotherapy. Indications, complications and practical performance].
    Heslet L; Lybecker H; Andersen PI
    Ugeskr Laeger; 1990 Sep; 152(37):2635-9. PubMed ID: 2219485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to the international forum on haemovigilance.
    Wiersum-Osselton JC; Schipperus MR
    Vox Sang; 2006 Oct; 91(3):278-9. PubMed ID: 16958843
    [No Abstract]   [Full Text] [Related]  

  • 11. Perceived safety of donor blood and blood substitutes for transfusion: the role of informational frame, patient groups and stress appraisals.
    Ferguson E; Leaviss J; Townsend E; Fleming P; Lowe KC
    Transfus Med; 2005 Oct; 15(5):401-12. PubMed ID: 16202055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood administration, risks, and substitutes.
    Fakhry SM; Sheldon GF
    Adv Surg; 1995; 28():71-92. PubMed ID: 7879691
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of haemorrhage with transfusion preparations and blood derivatives].
    Buliková A; Matýsková M; Penka M
    Vnitr Lek; 2008 Jun; 54(6):623-31. PubMed ID: 18672574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted infections.
    Bihl F; Castelli D; Marincola F; Dodd RY; Brander C
    J Transl Med; 2007 Jun; 5():25. PubMed ID: 17553144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance.
    Williamson L; Cohen H; Love E; Jones H; Todd A; Soldan K
    Vox Sang; 2000; 78 Suppl 2():291-5. PubMed ID: 10938972
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood doping and cardiovascular consequences].
    Gauthier J
    Presse Med; 2002 Dec; 31(40):1904-8. PubMed ID: 12579085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
    Cohn CS; Cushing MM
    Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man.
    Fukushima K; Nakamura M; Hinuma K
    Prog Clin Biol Res; 1983; 122():291-8. PubMed ID: 6878373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood transfusion and blood-derived products: prescription, complications. Risk management].
    Noizat-Pirenne F; Wautier JL
    Rev Prat; 2008 Mar; 58(6):679-85; quiz 685. PubMed ID: 18437959
    [No Abstract]   [Full Text] [Related]  

  • 20. Perceptions in transfusion medicine: a pilot field study on risk and ethics for blood and blood substitutes.
    Fleming P; Ferguson E; Townsend E; Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):149-56. PubMed ID: 17453701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.